Testimonials from our clients

When a potential client contacts Young Law Group to report corporate fraud or misconduct, the facts and circumstances don’t always give rise to a viable whistleblower claim under the False Claims Act or any of the federal agency whistleblower programs. There may, however, be other legal avenues to explore.  YLG has successfully represented lead plaintiffs in a number of class action lawsuits, including:

No. 14-cv-0350 (S.D.N.Y.)

U.F.C.W. Tri-State Pension Fund v. Barclays Bank

YLG Founder Eric L. Young represented one of the named plaintiffs in an anti-trust class action that resulted in a $2.3 billion settlement.  The class action complaint alleged that the settling defendants conspired to fix prices and engaged in manipulation of the foreign exchange market in violation of the Sherman Antitrust Act and the Commodity Exchange Act.

No. 1:17-md-02804 (N.D. Ohio)

In re: National Prescription Opiate Litigation

YLG represents one of the named plaintiffs, a third-party payor, in a case currently pending in the Opioid Multidistrict Litigation in the Northern District of Ohio. The lawsuit seeks recovery of payments to beneficiaries for opioid prescriptions as well as costs for medical treatment caused by the misuse and abuse of opioids. The complaint alleges that the defendants engaged in an orchestrated campaign that spread false and deceptive information about the risks of long-term use of opioids. The class action complaint asserts multiple theories of liability against the defendants including (i) violation of state consumer fraud laws; (ii) unjust enrichment; (iii) breach of implied warranties; (iv) civil conspiracy; and (v) negligence.

No. 19-cv-10356 (D. Mass.)

U.F.C.W. Health & Welfare Fund of Northeastern Pennsylvania v. Ranbaxy Inc.

YLG represented a named plaintiff in one of five consolidated class action lawsuits that resulted in a settlement of $485 million. The complaint alleged that two pharmaceutical manufacturers, and their subsidiaries, manipulated the FDA’s generic drug approval process to prevent competitive products from entering the market and forcing purchasers to pay artificially inflated prices for certain generic drugs. It was further alleged that the defendants’ actions violated RICO, federal and state antitrust laws, and state consumer protection laws.

No. 05-cv-0020 (E.D. Pa.)

Franco v. Ruiz Food Products, Inc.

YLG represented the named plaintiffs in a class action that resulted in a $2.5 million settlement. The complaint alleged that the defendant failed to properly compensate its hourly employees in violation of the Fair Labor Standards Act as well as multiple violations of the California Labor Code.

No. 06-cv-01344 (W.D. Pa.)

Figas v. Horsehead Corp.

YLG Founder Eric Young served as lead attorney for members of the United Steelworkers of America Local 8183, in a class action lawsuit that resulted in a $1.2 million settlement. The lawsuit was based on allegations that the defendant, a zinc producer, violated the Fair Labor Standards Act by refusing to pay production workers for time spent putting on and removing their protective clothing and equipment. Plaintiffs also sought compensation for time spent traveling to and from their respective work locations.

No. 07-cv-166 (E.D.N.C.)

Hosler v. Smithfield Packing Co

YLG represented employees who worked at the world’s largest pork processing facility in North Carolina. A class action lawsuit was filed to recover unpaid overtime as well as unpaid time spent on compensable activities under the Fair Labor Standards Act and North Carolina labor laws. A multi-million dollar settlement was reached with the defendant.

No. 10-cv-1194 (E.D. Pa.)

Ripley. v. Sunoco, Inc.

YLG represented plaintiffs in a class action filed on behalf of current and former operations and maintenance workers who were employed at Sunoco’s South Philadelphia refinery. The plaintiffs alleged that the defendant failed to pay wages and overtime for all required work time in violation of the federal Fair Labor Standards Act. The case resulted in a settlement in the amount of $675,000.

No. 11-cv-00282 (D. Mass.)

Healthcare Strategies, Inc. v. ING Life Ins. and Annuity Co.

YLG represented the named plaintiff Healthcare Strategies Inc. in a class action that resulted in a $14.9 million verdict. The class action complaint alleged that revenue sharing payments received by the defendant from mutual funds were prohibited transactions and violations of fiduciary duties under the Employee Retirement Income Security Act.

Find the Help You Need
If you have knowledge about fraudulent activity, contact us today.